We are emerging markets transaction advisors. Learn more about our exceptional staff and unprecedented level of expertise.
 

Our Team

Emerging Markets Senior Transaction Advisors

Our team of global advisors provides the experience and insight to guide your pharma, biotech, or device transaction through the challenging environment of emerging market commercialization.

Our 500 years of combined experience and diverse backgrounds provide the knowledge and ability to deliver immediate value to your organization at any point throughout the pharma/biotech/devices M&A, licensing and commercialization spectrum.

_DSC7649
Alan Vanderborght, MBA
Managing Director and CEO
18+ years of experience in international business development in the pharmaceutical industry. Head of commercial operations and business development for Bristol- Myers Squibb in 16 Latin American countries. Global management consultant. Speaks French and Spanish fluently. Completed nine transactions in global markets in the past three years.
_DSC7671-2
Nicolas Gikakis, MBA
Managing Director
18+ years of experience in the medical device and biotech fields. Global leadership positions at Pall, Terumo, and DSCP/Maquet, managing $200M business. Involved in several distribution, licensing, and M&A deals including the acquisition of brands from J&J, licensing of assets to Medtronic and Terumo, and integration of assets into existing commercial operations. Previous clinical and research background.
_DSC7658
Dr. Ernesto Neumann, MBA, Ph.D.
Managing Director Latin America
40 + years career with Merck KGaA in Latam. General Manager in Argentina, Brazil, Ecuador, Colombia, Mexico, Peru, and regional VP Latam Merck Serono which had sales of $1.3 B and 2800 employees. During his tenure at Merck, Dr. Neumann realized more than 10 transactions. Merck Serono has the largest sales share in Latam of all multinational companies.
_DSC7650-2
Ulrich Steuer, MBA
Managing Director Mexico
30+ years of experience in the pharmaceutical industry in Latam. General Manager for Bristol-Myers Squibb in Mexico and Argentina. Prior to that Ulrich was Vice President Latin America Marketing and Business Development for Aventis where he was responsible for the launch of Lantus® in the region as well as many other products. He also held the position of GM Venezuela for Aventis.
_DSC7665-2
Dr. Stephen Lee, Ph.D.
Managing Director Asia Pacific
15+ years of experience in the life sciences sector. 7 + years working in Hong Kong and Asia. Founded and worked for start-ups (CASiGEN Pharma, TianXing Biopharmaceutical, LifeQual Pharmaceuticals) Experience in consulting, business development, fund raising (Ventac Partners, Bio-Enabler, 3V SourceOne Capital, Applied Strategies), and in equity research (First State Investments), and patent law (USPTO).
_DSC7678-2
Dr. Khalid M. Alkharfy,Pharm D., Ph.D.
Managing Director Middle East and Africa
12 + years experience in pharmaceutical consultation, management, research, and product development Headed the Research Department of region’s fourth generation science park – Riyadh Techno Valley where he was responsible for managing R&D activities. Managing Director of a biotechnology incubator in Riyadh, Saudi Arabia
_DSC7663-2
Francisco Hidalgo, MBA
Managing Director Latin America
34+ years of experience in the pharmaceutical industry in Latam. General Manager of Brazil, Mexico, Puerto Rico, Caribbean Region, Colombia, Regional VP for Central and South America, and VP of Global Mature Product Portfolio, Geographic Optimization and Footprint, Tactical Divestitures and Distributor Markets Working Group for BMS. VP and COO of Procaps Group.
_DSC7661
Rubens Paulella, MBA Thunderbird
Advisor Brazil
17+ years of experience in the pharmaceutical industry in Latam, mostly in Brazil. Career evolution from Sales Rep to Business Unit Director and Marketing Director (companies such as J&J, Pharmacia&Upjohn, Wyeth, Bristol-Myers Squibb, Mundipharma). Several therapeutic areas expertise. Recent experience as Director of Origination, focused on new opportunities.
oye-olukotun
Dr. Oye Olukotun,MD, MPH, FACC
Advisor US
30 years experience in the pharma industry. CEO of Epigen Pharma and Vice Chairman of Cardiovax Inc., a biotech company developing innovative cardiovascular therapies. Co-founder and CMO of VIA Pharmaceuticals, CEO of of CR Strategies, LLC, a clinical research and development consulting firm, VP of Regulatory Affairs and CMO of Mallinckrodt, Inc., Director of diaDexus, Inc, past- Director of BioClinica, Nordion, & SemBiosys Genetics Inc.
oye-olukotun
Manfred Stadler, MBA
Managing Director Europe
40+ years of experience in management within multinational corporations,10 of which in the pharmaceutical industry. Assumed roles as CFO and COO of the German and Austrian affiliates of one of the leading international advertising agency networks. Headed the corporate development for Cambrex, where he prepared and executed numerous acquisition processes including post acquisition integration.
david-luery
David Luery
EVP Global Commercial Intelligence
25+ years of experience in global strategic market intelligence for the pharma industry. David has focused primarily on new product development, including market potential, positioning & messaging, and pricing. A majority of David’s work in the past 20 years has been international in scope, as his clients have primarily been EU-based global HQs; he has led teams based in London and in Amsterdam.
vijay-murugan
Vijay Murugan
International Finance Analyst
Extensive finance modeling experience including development of valuations scenarios for companies the rapid infectious disease market. Performed primary and secondary research in the equity market to inform investment decisions. Researched patient engagement trends in healthcare. Worked for Navigant consulting, Pfizer Global Supply Group, and PropThink LLC.